Works by KWEKKEBOOM, D. J.

Results: 16

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

Published in:

Clinical Endocrinology, 1996, v. 45, n. 6, p. 755, doi. 10.1046/j.1365-2265.1996.8650876.x

By:

De Herder, W. W.;
Reijs, A. E. M.;
Kwekkeboom, D. J.;
Hofland, L. J.;
Nobels, F. R. E.;
Oei, H. Y.;
Krenning, E. P.;
Lamberts, S. W. J.

Publication type:

Article

A case of antibody formation against octreotide visualized with.

Published in:

Clinical Endocrinology, 1993, v. 39, n. 2, p. 239, doi. 10.1111/j.1365-2265.1993.tb01780.x

By:

Kwekkeboom, D. J.;
Assies, J.;
Holland, L. J.;
Reubi, J. C.;
Lamberts, S. W. J.;
Krenning, E. P.

Publication type:

Article

Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or α-subunit secreting pituitary adenoma.

Published in:

Clinical Endocrinology, 1992, v. 36, n. 2, p. 171, doi. 10.1111/j.1365-2265.1992.tb00953.x

By:

Kwekkeboom, D. J.;
Lamberts, S. W. J.

Publication type:

Article

PROLONGED TREATMENT WITH THE GnRH ANALOGUE BUSERELIN DOES NOT AFFECT α-SUBUNIT PRODUCTION BY THE PITUITARY GONADOTROPH.

Published in:

Clinical Endocrinology, 1990, v. 32, n. 4, p. 443, doi. 10.1111/j.1365-2265.1990.tb00884.x

By:

KWEKKEBOOM, D. J.;
LAMBERTS, S. W. J.;
BLOM, J. H. M.;
SCHROEDER, F. H.;
JONG, F. H.

Publication type:

Article

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Differential Response of Bone Versus Soft Tissue Lesions.

Published in:

Neuroendocrinology, 2012, v. 96, p. 65

By:

Van Vliet, E. I.;
Hermans, J. J.;
De Ridder, M. A.;
Teunissen, J. J.;
Kam, B. L.;
De Krijger, R. R.;
Krenning, E. P.;
Kwekkeboom, D. J.

Publication type:

Article

Somatostatin and the immune and haematopoetic system; a review.

Published in:

European Journal of Clinical Investigation, 1994, v. 24, n. 2, p. 91, doi. 10.1111/j.1365-2362.1994.tb00972.x

By:

HAGEN, P. M. VAN;
KRENNING, E. P.;
KWEKKEBOOM, D. J.;
REUBI, J. C.;
ANKER-LUGTENBURG, Vd. P. J.;
LÖWENBERG, B.;
LAMBERTS, S. W. J.

Publication type:

Article

Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1346, doi. 10.1007/s00259-006-0172-9

By:

Esser, J. P.;
Krenning, E. P.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
van Gameren, A. L. H.;
Bakker, W. H.;
Kwekkeboom, D. J.

Publication type:

Article

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 417, doi. 10.1007/s00259-002-1050-8

By:

Kwekkeboom, D. J.;
Bakker, W. H.;
Kam, B. L.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
de Herder, W. W.;
Feelders, R. A.;
van Eijck, C. H. J.;
de Jong, M.;
Srinivasan, A.;
Erion, J. L.;
Krenning, E. P.

Publication type:

Article

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Published in:

Clinical & Experimental Immunology, 2013, v. 174, n. 2, p. 256, doi. 10.1111/cei.12183

By:

Van der Weerd, K.;
Van Hagen, P. M.;
Schrijver, B.;
Kwekkeboom, D. J.;
De Herder, W. W.;
Ten Broek, M. R. J.;
Postema, P. T. E.;
Van Dongen, J. J. M.;
Staal, F. J. T.;
Dik, W. A.

Publication type:

Article

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 11, p. 3381, doi. 10.1210/jc.2011-1563

By:

van Schaik, E.;
van Vliet, E. I.;
Feelders, R. A.;
Krenning, E. P.;
Khan, S.;
Kamp, K.;
Valkema, R.;
van Nederveen, F. H.;
Teunissen, J. J. M.;
Kwekkeboom, D. J.;
de Herder, W. W.

Publication type:

Article

Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma.

Published in:

European Journal of Endocrinology, 2000, v. 143, n. 5, p. 615

By:

Nobels, F. R. E.;
de Herder, W. W.;
van den Brink, W. M.;
Kwekkeboom, D. J.;
Hofland, L. J.;
Zuyderwijk, J.;
de Jong, F. H.;
Lamberts, S. W. J.

Publication type:

Article

Efficacy of adalimumab in sarcoidosis.

Published in:

2010

By:

Kamphuis, L. S. J.;
Lam-Tse, W. K.;
Dik, W. A.;
Bastiaans, J.;
van Biezen, P.;
van Daele, P. L. A.;
Kwekkeboom, D. J.;
Kuijpers, R. W. A. M.;
Baarsma, G. S.;
van Hagen, P. M.;
Hooijkaas, H.;
van Laar, J. A. M.

Publication type:

Abstract

Somatostatin-receptor Scintigraphy in Gastroenteropancreatic Tumors.

Published in:

Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 416, doi. 10.1111/j.1749-6632.1994.tb17291.x

By:

KRENNING, E. P.;
KWEKKEBOOM, D. J.;
OEI, H. Y.;
JONG, R. J. B.;
DOP, F. J.;
REUBI, J. C.;
LAMBERTS, S. W. J.

Publication type:

Article

Radiotherapy with a Radiolabeled Somatostatin Analogue, [111In-DTPA- d-Phe1]-Octreotide.

Published in:

Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 496, doi. 10.1111/j.1749-6632.1994.tb17300.x

By:

KRENNING, E. P.;
KOOIJ, P. P. M.;
BAKKER, W. H.;
BREEMAN, W. A. P.;
POSTEMA, P. T. E.;
KWEKKEBOOM, D. J.;
OEI, H. Y.;
JONG, M.;
VISSER, T. J.;
REIJS, A. E. M.;
LAMBERTS, S. W. J.

Publication type:

Article

Cost-Effectiveness Analysis of Somatostatin Receptor Scintigraphy.

Published in:

Journal of Nuclear Medicine, 1996, v. 37, n. 6, p. 886

By:

Kwekkeboom, D. J.;
Lamberts, S. W. J.;
Habbema, J. D. F.;
Krenning, E. P.

Publication type:

Article

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.

Published in:

Journal of Nuclear Medicine, 1992, v. 33, n. 5, p. 652

By:

Krenning, E. P.;
Bakker, W. H.;
Kooij, P. P. M.;
Breeman, W. A. P.;
Oei, H. Y.;
de Jong, M.;
Reubi, J. C.;
Visser, T. J.;
Bruns, C.;
Kwekkeboom, D. J.;
Reijs, A. E. M.;
van Hagen, P. M.;
Koper, J. W.;
Lamberts, S. W. J.

Publication type:

Article

Works by KWEKKEBOOM, D. J.

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

A case of antibody formation against octreotide visualized with.

Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or α-subunit secreting pituitary adenoma.

PROLONGED TREATMENT WITH THE GnRH ANALOGUE BUSERELIN DOES NOT AFFECT α-SUBUNIT PRODUCTION BY THE PITUITARY GONADOTROPH.

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Differential Response of Bone Versus Soft Tissue Lesions.

Somatostatin and the immune and haematopoetic system; a review.

Comparison of [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate and [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotide: which peptide is preferable for PRRT?

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy.

Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma.

Efficacy of adalimumab in sarcoidosis.

Somatostatin-receptor Scintigraphy in Gastroenteropancreatic Tumors.

Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In-DTPA- d-Phe<sup>1</sup>]-Octreotide.

Cost-Effectiveness Analysis of Somatostatin Receptor Scintigraphy.

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.